Sign in
4

Changes in Ownership

Kymera Therapeutics, Inc. Filed Acc 0001209191-22-061706

10% owner sold 382,244 shares at an average $31.36 ($11,985,954)

From the SEC's structured data for this filing

Trades in this filing

Atlas Venture Fund X, L.P. · 10% owner

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-14 Sale : show line 1 in the form −112,819 $30.28 $3,416,159 5,252,744 D
2022-12-14 Sale : show line 2 in the form −101,189 $31.44 $3,181,382 5,151,555 D
2022-12-14 Sale : show line 3 in the form −54,737 $32.33 $1,769,647 5,096,818 D
2022-12-14 Sale : show line 4 in the form −13,997 $33.34 $466,660 5,082,821 D
2022-12-14 Sale : show line 5 in the form −13,335 $34.02 $453,657 5,069,486 D
2022-12-14 Sale : show line 6 in the form −31,584 $30.28 $956,364 969,833 I
2022-12-14 Sale : show line 7 in the form −28,329 $31.44 $890,664 941,504 I
2022-12-14 Sale : show line 8 in the form −15,324 $32.33 $495,425 926,180 I
Open-market sales · 382,244 sh · avg $31.36 · $11,985,954
Loading xslF345X03/doc4.xml…